Hydroxycarboxylic acid receptors are essential for breast cancer cells to control their lipid/fatty acid metabolism

Oncotarget

Volumn 6, Issue 23, 2015, Pages 19706-19720

  Stäubert, Claudia ^a,b,c   Broom, Oliver Jay ^b   Nordström, Anders ^a,b  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Cancer metabolism; GPR109a; GPR81; Hydroxycarboxylic acid receptors; Metabolite sensing GPCRs

Indexed keywords

1 (1 METHYLETHYL) 1H BENZOTRIAZOLE 5 CARBOXYLIC ACID; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ALPHA RESORCYLIC ACID; CASPASE 3; CASPASE 7; CYCLIC AMP; ETOMOXIR; G PROTEIN COUPLED RECEPTOR; HYDROXYCARBOXYLIC ACID RECEPTOR 1; HYDROXYCARBOXYLIC ACID RECEPTOR 3; MESSENGER RNA; PERHEXILINE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CARNITINE PALMITOYLTRANSFERASE; ENZYME INHIBITOR; EPOXIDE; FATTY ACID; GPR81 PROTEIN, HUMAN; HCAR3 PROTEIN, HUMAN; NICOTINIC RECEPTOR;

APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; CELL LEVEL; CELL METABOLISM; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVATION; FATTY ACID METABOLISM; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLIC REGULATION; ANTAGONISTS AND INHIBITORS; BREAST NEOPLASMS; CELL DEATH; CELL PROLIFERATION; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; LIPID METABOLISM; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TIME FACTOR; TUMOR CELL CULTURE; TUMOR CELL LINE;

BREAST NEOPLASMS; CARNITINE O-PALMITOYLTRANSFERASE; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATOGRAPHY, LIQUID; ENZYME INHIBITORS; EPOXY COMPOUNDS; FATTY ACIDS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; LIPID METABOLISM; OXIDATION-REDUCTION; PERHEXILINE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NICOTINIC; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 84937801681     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3565     Document Type: Article

References (35)

1. Vander Heiden MG, Cantley LC and Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009; 324(5930):1029-1033.
2. Carracedo A, Cantley LC and Pandolfi PP. Cancer metabolism: fatty acid oxidation in the limelight. Nature reviews Cancer. 2013; 13(4):227-232.
3. Zhao Y, Butler EB and Tan M. Targeting cellular metabolism to improve cancer therapeutics. Cell death & disease. 2013; 4:e532.
4. Vander Heiden MG. Targeting cancer metabolism: a therapeutic window opens. Nature reviews Drug discovery. 2011; 10(9):671-684.
5. Menendez JA. Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: molecular mechanisms and therapeutic perspectives. Biochimica et biophysica acta. 2010; 1801(3):381-391.
6. Drews J. Drug discovery: A historical perspective. Science. 2000; 287(5460):1960-1964.
7. Lundstrom K. An overview on GPCRs and drug discovery: structure-based drug design and structural biology on GPCRs. Methods in molecular biology. 2009; 552:51-66.
8. Blad CC, Tang C and Offermanns S. G protein-coupled receptors for energy metabolites as new therapeutic targets. Nature reviews Drug discovery. 2012; 11(8):603-619.
9. Offermanns S. Free fatty acid (FFA) and hydroxy carboxylic acid (HCA) receptors. Annual review of pharmacology and toxicology. 2014; 54:407-434.
10. Offermanns S, Colletti SL, Lovenberg TW, Semple G, Wise A and IJzerman AP. International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B). Pharmacological reviews. 2011; 63(2):269-290.
11. Santolla MF, De Francesco EM, Lappano R, Rosano C, Abonante S and Maggiolini M. Niacin activates the G protein estrogen receptor (GPER)-mediated signalling. Cellular signalling. 2014; 26(7):1466-1475.
12. Liu C, Wu J, Zhu J, Kuei C, Yu J, Shelton J, Sutton SW, Li X, Yun SJ, Mirzadegan T, Mazur C, Kamme F and Lovenberg TW. Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81. The Journal of biological chemistry. 2009; 284(5):2811-2822.
13. Ahmed K, Tunaru S, Tang C, Muller M, Gille A, Sassmann A, Hanson J and Offermanns S. An autocrine lactate loop mediates insulin-dependent inhibition of lipolysis through GPR81. Cell metabolism. 2010; 11(4):311-319.
14. Cai TQ, Ren N, Jin L, Cheng K, Kash S, Chen R, Wright SD, Taggart AK and Waters MG. Role of GPR81 in lactate-mediated reduction of adipose lipolysis. Biochemical and biophysical research communications. 2008; 377(3):987-991.
15. Taggart AK, Kero J, Gan X, Cai TQ, Cheng K, Ippolito M, Ren N, Kaplan R, Wu K, Wu TJ, Jin L, Liaw C, Chen R, Richman J, Connolly D, Offermanns S, et al. (D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. The Journal of biological chemistry. 2005; 280(29):26649-26652.
16. Ahmed K, Tunaru S, Langhans CD, Hanson J, Michalski CW, Kolker S, Jones PM, Okun JG and Offermanns S. Deorphanization of GPR109B as a receptor for the beta-oxidation intermediate 3-OH-octanoic acid and its role in the regulation of lipolysis. The Journal of biological chemistry. 2009; 284(33):21928-21933.
17. Liu C, Kuei C, Zhu J, Yu J, Zhang L, Shih A, Mirzadegan T, Shelton J, Sutton S, Connelly MA, Lee G, Carruthers N, Wu J and Lovenberg TW. 3,5-Dihydroxybenzoic acid, a specific agonist for hydroxycarboxylic acid 1, inhibits lipolysis in adipocytes. The Journal of pharmacology and experimental therapeutics. 2012; 341(3):794-801.
18. Hanson J, Gille A, Zwykiel S, Lukasova M, Clausen BE, Ahmed K, Tunaru S, Wirth A and Offermanns S. Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice. The Journal of clinical investigation. 2010; 120(8):2910-2919.
19. Semple G, Skinner PJ, Cherrier MC, Webb PJ, Sage CR, Tamura SY, Chen R, Richman JG and Connolly DT. 1-Alkyl-benzotriazole-5-carboxylic acids are highly selective agonists of the human orphan G-protein-coupled receptor GPR109b. Journal of medicinal chemistry. 2006; 49(4):1227-1230.
20. Zhou Q, Li G, Deng XY, He XB, Chen LJ, Wu C, Shi Y, Wu KP, Mei LJ, Lu JX and Zhou NM. Activated human hydroxy-carboxylic acid receptor-3 signals to MAP kinase cascades via the PLC-dependent PKC and MMP-mediated EGFR pathways. British journal of pharmacology. 2012; 166(6):1756-1773.
21. Roland CL, Arumugam T, Deng D, Liu SH, Philip B, Gomez S, Burns WR, Ramachandran V, Wang H, Cruz-Monserrate Z and Logsdon CD. Cell surface lactate receptor GPR81 is crucial for cancer cell survival. Cancer research. 2014; 74(18):5301-5310.
22. Elangovan S, Pathania R, Ramachandran S, Ananth S, Padia RN, Lan L, Singh N, Martin PM, Hawthorn L, Prasad PD, Ganapathy V and Thangaraju M. The niacin/butyrate receptor GPR109A suppresses mammary tumorigenesis by inhibiting cell survival. Cancer research. 2013.
23. Thangaraju M, Cresci GA, Liu K, Ananth S, Gnanaprakasam JP, Browning DD, Mellinger JD, Smith SB, Digby GJ, Lambert NA, Prasad PD and Ganapathy V. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer research. 2009; 69(7):2826-2832.
24. Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, Thangaraju M, Prasad PD, Manicassamy S, Munn DH, Lee JR, Offermanns S and Ganapathy V. Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis. Immunity. 2014.
25. Martinez-Outschoorn UE, Lin Z, Whitaker-Menezes D, Howell A, Sotgia F and Lisanti MP. Ketone body utilization drives tumor growth and metastasis. Cell cycle. 2012; 11(21):3964-3971.
26. Kallinowski F, Vaupel P, Runkel S, Berg G, Fortmeyer HP, Baessler KH, Wagner K, Mueller-Klieser W and Walenta S. Glucose uptake, lactate release, ketone body turnover, metabolic micromilieu, and pH distributions in human breast cancer xenografts in nude rats. Cancer research. 1988; 48(24 Pt 1):7264-7272.
27. Costa CG, Dorland L, Holwerda U, de Almeida IT, Poll-The BT, Jakobs C and Duran M. Simultaneous analysis of plasma free fatty acids and their 3-hydroxy analogs in fatty acid beta-oxidation disorders. Clinical chemistry. 1998; 44(3):463-471.
28. Jones PM, Burlina AB and Bennett MJ. Quantitative measurement of total and free 3-hydroxy fatty acids in serum or plasma samples: short-chain 3-hydroxy fatty acids are not esterified. Journal of inherited metabolic disease. 2000; 23(7):745-750.
29. Jones PM, Tjoa S, Fennessey PV, Goodman SI and Bennett MJ. Addition of quantitative 3-hydroxy-octadecanoic acid to the stable isotope gas chromatography-mass spectrometry method for measuring 3-hydroxy fatty acids. Clinical chemistry. 2002; 48(1):176-179.
30. Ahmed K, Tunaru S and Offermanns S. GPR109A, GPR109B and GPR81, a family of hydroxy-carboxylic acid receptors. Trends in pharmacological sciences. 2009; 30(11):557-562.
31. Violante S, Ijlst L, Te Brinke H, Koster J, Tavares de Almeida I, Wanders RJ, Ventura FV and Houten SM. Peroxisomes contribute to the acylcarnitine production when the carnitine shuttle is deficient. Biochimica et biophysica acta. 2013; 1831(9):1467-1474.
32. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J and Wittwer CT. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clinical chemistry. 2009; 55(4):611-622.
33. Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S and Madden TL. Primer-BLAST: a tool to design targetspecific primers for polymerase chain reaction. BMC bioinformatics. 2012; 13:134.
34. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A and Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome biology. 2002; 3(7):RESEARCH0034.
35. Andersen CL, Jensen JL and Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer research. 2004; 64(15):5245-5250.